Clinical Trials Logo
  1. Home
  2. Swallowing Disorders
  3. NCT02075385

Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer — Swallowing-1  

Head Neck Cancer Clinical Trial

Official title:
Randomized Phase II Trial: Swallowing Speech Pathology Intervention During Radiochemotherapy on Patients With Head and Neck Cancer

Clinical Trial Summary

General Objective: To evaluate the swallowing results of speech pathologist rehabilitation of advanced oropharynges, larynx and hypopharynx cancer patients during neoadjuvant chemotherapy and radiotherapy concomitant to chemotherapy.

Methods and Casuistic: Randomized clinical trial phase II. 80 patients with advanced oropharynges, larynx and hypopharynx cancer diagnoses from Barretos Cancer Hospital, which had the proposal of neoadjuvant chemotherapy followed by radiotherapy combined with chemotherapy. Patients are randomized on two groups: control group and speech pathology therapy group

Clinical Trial Description

To evaluate and compare the swallowing and life quality swallowing on a group undergoing to speech pathology therapy (intervention) and a control group (no intervention). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02075385
Study type Interventional
Source Barretos Cancer Hospital
Contact
Status Completed
Phase Phase 2
Start date July 2012
Completion date August 2015
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04566367 - Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer N/A
Terminated NCT02521870 - A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Phase 1/Phase 2
Recruiting NCT05572684 - A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT02268344 - Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection N/A
Terminated NCT00198328 - Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma Phase 3
Recruiting NCT04858269 - First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients Phase 2
Recruiting NCT05878964 - Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
Recruiting NCT03051269 - Calcium Electroporation for Head and Neck Cancer Phase 1
Completed NCT05833841 - Swallowing Function in Patients With Head and Neck Cancers N/A
Withdrawn NCT03747562 - Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients. Phase 3
Completed NCT03572829 - Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC Phase 2
Recruiting NCT02549742 - Electrochemotherapy on Head and Neck Cancer Phase 2
Completed NCT01951664 - Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors N/A
Recruiting NCT05838729 - Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer Phase 1/Phase 2
Completed NCT03832686 - Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer N/A
Recruiting NCT05382585 - Newer Therapeutic Targets in Head and Neck Cancers